Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0119
BRL/USD 0,1941
INR/USD 0,0104
CNY/USD 0,1493
ZAR/USD 0,0615
IDR/USD 0,0001
SPACE FOR MEDIA DIPLOMACY
20:00 «Russian Lessons with Tanya Semke»
20:00 «Russian Lessons with Tanya Semke»
Now 16+
20:00

«Russian Lessons with Tanya Semke»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
20:15 «Laboratorium»
Next
20:15

«Laboratorium»

16+
20:30

«Lеt's be clear»

16+
21:00

«BRICSreport»

16+
Menu

New Iranian anti-cancer drug promises longer life without common side effects

It will minimise common side effects such as hair loss and weight loss


An Iranian biotech company has announced the development of an innovative anti-cancer drug that promises to extend the lives of patients while minimising common side effects such as hair loss and weight loss. This is reported by ParsToday, a partner of TV BRICS.

The new therapy utilises antibody–drug conjugates or ADCs technology, which enables the medication to directly target cancerous tissues. This combination of immunotherapy and chemotherapy delivers higher efficacy while reducing the dosage needed for treatment. 

It was introduced the drug, designed to treat breast cancer and certain digestive cancers. Experts say that the targeted approach not only enhances treatment effectiveness but also leads to significantly fewer adverse effects. 

Photo: iStock